Completed NA INTERVENTIONAL 2-arm NCT01620034

Lung Stereotactic Body Radiotherapy (SBRT) Delivered Over 4 Days Versus 11 Days

A Randomized Study of Stereotactic Body Radiotherapy (SBRT) for Lung Tumours Delivered Over 4 Days Versus 11 Days

Sponsor: Sunnybrook Health Sciences Centre

Conditions Peripherally Located Solitary Lung Metastasis Peripherally Located Stage I Lung Cancer

Interventions Stereotactic Body Radiotherapy

Updated 6 times since 2017 Last updated: May 3, 2018 Started: May 31, 2010 Primary completion: Aug 31, 2012 Completion: May 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Peripherally Located Solitary Lung Metastasis and Peripherally Located Stage I Lung Cancer, this trial is completed. The trial is conducted by Sunnybrook Health Sciences Centre and has accumulated 6 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE2 → NA
Jul 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sunnybrook Health Sciences Centre

Data source: Sunnybrook Health Sciences Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada